Citations

Mayo Clinic

Showing 10 of 108522 citations.

Salvage of Failed Total Ankle Replacement Using Tantalum Trabecular Metal: Case Series
Sagherian, Bernard H. , Claridge, Richard J.

Foot & Ankle International | November 7, 2014 | Volume: 36 | Issue: 3 | Pages: 318-324

10.1177/1071100714556760 | PMID 25377387 Get It

Background: Although newer generations of total ankle arthroplasty designs have better clinical outcomes, failure due to aseptic loosening remains a frequent major complication. Arthrodesis is the most common salvage procedure for a failed total ankle replacement. There are several arthrodesis techniques each with its advantages and disadvantages. We present a technique of ankle arthrodesis for failed total ankle replacements using tantalum Trabecular Metal™ (Zimmer, Warsaw, IN) with internal fixation, thus sparing the subtalar joint. Methods: Three patients who had undergone arthrodesis for a failed total ankle replacement using tantalum Trabecular Metal were retrospectively reviewed. The mean follow-up period was 57 (range, 31-86) months. The mean age at ankle arthroplasty was 57 (range, 33-72) years and at ankle arthrodesis was 63 (range, 44-74) years. The mean time from arthroplasty to arthrodesis was 7 (range, 2-11) years. Results: The American Orthopaedic Foot and Ankle Society (AOFAS) score improved from 30.7 (range, 20-39) preoperatively to 72.7 (range, 65-77) postoperatively at the time of last follow-up. Arthrodesis was achieved at a mean of 3 months, and there were no complications. Conclusion: The technique described has several advantages when compared to other methods of salvage ankle arthrodesis. The subtalar joint is not included in the fusion unless it is degenerative and symptomatic. Height of the ankle is maintained throughout the fusion process. Furthermore, Trabecular Metal is abundantly available; it avoids donor site morbidity and eliminates the risk of transmissible diseases. Level of Evidence: Level V, expert opinion.
Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia
Ojha, Juhi, Ayres-Silva, Jackline de Paula , Secreto, Charla, Tschumper, Renee C. , Rabe, Kari G. , Dyke, Daniel Van, Braggio, Esteban , Tschumper, Renee, Rabe, Kari, Van Dyke, Daniel, Slager, Susan, Dyke, Daniel L. Van , Slager, Susan L. , Shanafelt, Tait D. , Fonseca, Rafaël , Kay, Neil E. , Chaffee, Kari G. , Braggio, Esteban

Blood | November 6, 2014 | Volume: 125 | Issue: 3 | Pages: 492-498

10.1182/blood-2014-06-580563 | PMID 25377784 Get It

Key Points Deep sequencing identifies a significant reservoir of subclonal mutations affecting key genes in CLL pathogenesis. Convergent evolution of genetic lesions in tumor subclonal populations is recurrently found in CLL.
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Painter, Jodie N. , Batra, Jyotsna , Cheng, Timothy, Lose, Felicity , Dennis, Joe, Michailidou, Kyriaki , Ahmed, Shahana, Ferguson, Kaltin , Healey, Catherine S., Kaufmann, S., Hillman, Kristine M. , Walpole, Carina , Moya, Leire , Pollock, Pamela M. , Jones, Angela, Howarth, Kimberley, Martin, L. J., Gorman, Maggie, Hodgson, Shirley, (NSECG), National Study of Endometrial Cancer Genetics Group, Polanco, Ma. Magdalena Echeverry De, Sans, Monica, Carracedo, Angel, Castellvi-Bel, Sergi, Rojas-Martinez, Augusto, Santos, Erika, Teixeira, Manuel R., Carvajal-Carmona, Luis, Shu, Xiao-Ou, Long, Jirong, Zheng, Wei, Xiang, Yong-Bing, (ANECS), The Australian National Endometrial Cancer Study Group, Montgomery, Grant W., Webb, Penelope M., Scott, Rodney J., McEvoy, Mark, Attia, John, Holliday, Elizabeth, Martin, Nicholas G., Nyholt, Dale R., Henders, Anjali K., Fasching, Peter A., Hein, Alexander, Beckmann, Matthias W., Renner, Stefan P., Dörk, Thilo, Hillemanns, Peter, Dürst, Matthias, Runnebaum, Ingo, Lambrechts, Diether, Coenegrachts, Lieve, Schrauwen, Stefanie, Amant, Frederic, Winterhoff, Boris, Dowdy, Sean C., Goode, Ellen L., Teoman, Attila, Salvesen, Helga B., Trovik, Jone, Njolstad, Tormund S., Werner, Henrica M.J., Ashton, Katie, Proietto, Tony, Otton, Geoffrey, Tzortzatos, Gerasimos, Mints, Miriam, Tham, Emma, RENDOCAS, Hall, Per, Czene, Kamila, Liu, Jianjun, Li, Jingmei, Hopper, John L., Southey, Melissa C., (AOCS), Australian Ovarian Cancer Study, Ekici, Arif B., Ruebner, Matthias, Johnson, Nicola, Peto, Julian, Burwinkel, Barbara, Marme, Frederik, Brenner, Hermann, Dieffenbach, Aida K., Meindl, Alfons, Brauch, Hiltrud, Network, The GENICA, Lindblom, Annika, Depreeuw, Jeroen, Moisse, Matthieu, Chang-Claude, Jenny, Rudolph, Anja, Couch, Fergus J., Olson, Janet E., Giles, Graham G., Bruinsma, Fiona, Cunningham, Julie M., Fridley, Brooke L., Børresen-Dale, Anne-Lise, Kristensen, Vessela N., Cox, Angela, Swerdlow, Anthony J., Orr, Nicholas, Bolla, Manjeet K., Wang, Qin, Weber, Rachel Palmieri, Chen, Zhihua, Shah, Mitul, French, Juliet D., Pharoah, Paul D.P., Dunning, Alison M., Tomlinson, Ian, Easton, Douglas F., Edwards, Stacey L., Thompson, Deborah J., Spurdle, Amanda B., Webb, Penelope M. , Chenevix‐Trench, Georgia , Spurdle, Amanda B. , Brauch, Hiltrud , Dörk, Thilo , Cox, Angela , Giles, Graham G. , Southey, Melissa C. , Zheng, Wei , Shu, Xiao‐Ou , Long, Jirong , Dunning, Alison M. , Lindblom, Annika , Ekici, Arif B. , Czene, Kamila , Liu, Jianjun , Carracedo, Ángel , Hein, Alexander , Hillemanns, Peter , Lambrechts, Diether , Martin, Nicholas G. , Montgomery, Grant W. , Brenner, Hermann , Swerdlow, Anthony J. , Orr, Nick , Li, Jingmei , Bowtell, David D.L. , Weber, Rachel Palmieri , Nyholt, Dale R. , Rabstein, Sylvia , Lotz, Anne , Moisse, Matthieu , Teixeira, Manuel R. , French, Juliet D. , McEvoy, Mark , Njølstad, Tormund S. , Tham, Emma , Renner, Stefan P. , Henders, Anjali K. , Lambrechts, Diether , Rogatto, Sílvia Regina , Nicklin, James , Scott, Rodney J. , O’Mara, Tracy A. , Cheng, Timothy, Dennis, Joe, Tyrer, Jonathan P. , Ahmed, Shahana, Jones, Angela, Howarth, Kimberley, Gorman, Maggie, (NSECG), National Study of Endometrial Cancer Genetics Group, Polanco, Ma. Magdalena Echeverry De, Sans, Monica, Carracedo, Angel, Castellvi-Bel, Sergi, Rojas-Martinez, Augusto, Santos, Erika, Teixeira, Manuel R., Carvajal-Carmona, Luis, Shu, Xiao-Ou, Long, Jirong, Zheng, Wei, Xiang, Yong-Bing, (ANECS), The Australian National Endometrial Cancer Study Group, Montgomery, Grant W., Webb, Penelope M., Scott, Rodney J., McEvoy, Mark, Attia, John, Holliday, Elizabeth, Martin, Nicholas G., Nyholt, Dale R., Henders, Anjali K., Fasching, Peter A., Hein, Alexander, Beckmann, Matthias W., Renner, Stefan P., Dörk, Thilo, Hillemanns, Peter, Dürst, Matthias, Runnebaum, Ingo, Lambrechts, Diether, Coenegrachts, Lieve, Schrauwen, Stefanie, Amant, Frederic, Winterhoff, Boris, Dowdy, Sean C., Goode, Ellen L., Teoman, Attila, Salvesen, Helga B., Trovik, Jone, Njolstad, Tormund S., Werner, Henrica M.J., Ashton, Katie, Proietto, Tony, Otton, Geoffrey, Tzortzatos, Gerasimos, Mints, Miriam, Tham, Emma, RENDOCAS, Hall, Per, Czene, Kamila, Liu, Jianjun, Li, Jingmei, Hopper, John L., Southey, Melissa C., (AOCS), Australian Ovarian Cancer Study, Ekici, Arif B., Ruebner, Matthias, Johnson, Nicola, Peto, Julian, Burwinkel, Barbara, Marme, Frederik, Brenner, Hermann, Dieffenbach, Aida K., Meindl, Alfons, Brauch, Hiltrud, Network, The GENICA, Lindblom, Annika, Depreeuw, Jeroen, Moisse, Matthieu, Chang-Claude, Jenny, Rudolph, Anja, Couch, Fergus J., Olson, Janet E., Giles, Graham G., Bruinsma, Fiona, Cunningham, Julie M., Fridley, Brooke L., Børresen-Dale, Anne-Lise, Kristensen, Vessela N., Cox, Angela, Swerdlow, Anthony J., Orr, Nicholas, Bolla, Manjeet K., Wang, Qin, Weber, Rachel Palmieri, Chen, Zhihua, Shah, Mitul, French, Juliet D., Pharoah, Paul D.P., Dunning, Alison M., Tomlinson, Ian, Easton, Douglas F., Edwards, Stacey L., Thompson, Deborah J., Spurdle, Amanda B., Dörk, Thilo , Lambrechts, Diether , Giles, Graham G , Spurdle, Amanda B , Teixeira, Manuel R , Webb, Penelope M , Hein, Alexander , Hillemanns, Peter , Swerdlow, Anthony J , Southey, Melissa C , Martin, Nicholas G , Rogatto, S R , Shu, Xiao-Ou , Dunning, Alison M , Lambrechts, Diether , Brenner, Hermann , Cox, Angela , Li, Jingmei , Ekici, Arif B , Moisse, Matthieu , Michailidou, Kyriaki , Chenevix-Trench, Georgia , Zheng, Wei , Czene, Kamila , Bowtell, David D , Batra, Jyotsna , Brauch, Hiltrud , Lindblom, Annika , Orr, Nick , Liu, Jing

Human Molecular Genetics | November 6, 2014 | Volume: 24 | Issue: 5 | Pages: 1478-1492

10.1093/hmg/ddu552 | PMID 25378557 Get It

Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma
Lagana, Stephen M. , Salomao, Marcela , Remotti, Helen , Knisely, A. S. , Moreira, Roger K. , Salomao, Marcela

Histopathology | November 6, 2014 | Volume: 66 | Issue: 4 | Pages: 598-602

10.1111/his.12601 | PMID 25378077 Get It

AimsBile salt export pump (BSEP) is a transporter expressed exclusively at hepatic canaliculi and drives bile‐salt efflux. Minimal data exist about BSEP expression in tumours. We hypothesized that BSEP immunohistochemistry would be specific for hepatocellular carcinoma (HCC).Methods and resultsTissue microarrays, including 48 HCC, 41 cholangiocarcinomas and 24 metastatic tumours in liver, were immunostained for BSEP. Expression was compared with common markers of hepatocytic differentiation including CD10, hepatocyte paraffin‐1 antigen (HepPar‐1), carcinoembryonic antigen, arginase‐1 (ARG) and glypican‐3 (GPC‐3). BSEP expression was assessed in normal tissues. Special attention was given to adrenal gland (normal and neoplasia). BSEP was easy to interpret and showed no background staining. Canalicular expression was seen in all normal livers, but not in other normal tissue. BSEP was 90% sensitive and 100% specific for HCC (canalicular in 33 of 43 positive cases). The sensitivity of ARG was slightly higher, but specificity was slightly lower (94% for both). HepPar‐1 was 90% sensitive and 97% specific. CD10, polyclonal carcinoembryonic antigen (pCEA) and GPC‐3 all had lower sensitivity (74, 81 and 54%, respectively).ConclusionsIn malignant tumours in the liver, BSEP marking was 100% specific and 90% sensitive for HCC. The specificity of BSEP for HCC obviates the need to identify a ‘canalicular’ pattern, which can limit the utility of other canalicular markers.
Is anesthetic exposure in early life associated with ADHD?
Schroeder, Darrell R. , Hansen, Tom G. , Šprung, Juraj , Warner, David O. , Schroeder, Darrell

Pediatric Anesthesia | November 6, 2014 | Volume: 24 | Issue: 12 | Pages: 1305-1306

10.1111/pan.12536 | PMID 25378040 Get It

Health Care Outcomes and Advance Care Planning in Older Adults Who Receive Home-Based Palliative Care: A Pilot Cohort Study
Chen, Christina Y. , Cha, Stephen S., Hanson, Gregory J. , Rahman, Parvez, Naessens, James M. , Takahashi, Paul Y. , Thorsteinsdottir, Bjorg , Cha, Stephen S., Peterson, Stephanie M. Peck , Takahashi, Paul

Journal of Palliative Medicine | November 6, 2014 | Volume: 18 | Issue: 1 | Pages: 38-44

10.1089/jpm.2014.0150 | PMID 25375663 Get It

Multiple myeloma after kidney transplantation
Safadi, Sami , Dispenzieri, Angela , Amer, Hatem , Hayman, Suzanne R. , Lacy, Martha Q. , Leung, Nelson , Gertz, Morie A. , Rajkumar, S. Vincent , Leung, Nelson , Dispenzieri, Angela , Amer, Hatem

Clinical Transplantation | November 6, 2014 | Volume: 29 | Issue: 1 | Pages: 76-84

10.1111/ctr.12482 | PMID 25377159 Get It

AbstractBackgroundData regarding multiple myeloma (MM) that develops after kidney transplantation (KTx) are scarce. The outcomes of these patients were evaluated in a retrospective study.MethodsPatients with newly diagnosed MM after KTx were selected. Patients with a diagnosis of MM or those who received treatment for monoclonal gammopathy of renal significance (MGRS) prior to KTx were excluded.ResultsBetween 2001 and 2012, seven patients developed MM after KTx. Reasons for ESRD included ADPKD (1), C1q nephropathy (1), MPGN (2), hypertensive nephrosclerosis (2), and chronic interstitial nephritis (1). Before KTx, only four patients had monoclonal protein studies, four had monoclonal gammopathy of undermined significance (MGUS), and two of them had clonal plasma cells in bone marrow. Median follow‐up after MM was 70 months (range 19–100). Median survival was 80 months. Median time from KTx to MM was 72 months (range 3–204 months). The Kidney allograft failed in four patients due to monoclonal protein‐related renal disease. Five patients received chemotherapy: bortezomib (n = 3), lenalidomide (n = 2), melphalan (n = 1), thalidomide (n = 1), pomalidomide (n = 1), and high‐dose dexamethasone (n = 1). Three patients received ASCT.ConclusionMultiple myeloma after KTx is rare. Most patients who develop MM had MGUS prior to KTx. There is significant renal involvement in these patients. Survival is not worse when compared to MM without KTx. Further work is needed to identify the best treatment options for these patients.
Genetic Markers Associated With Plasma Protein C Level in African Americans: The Atherosclerosis Risk in Communities (ARIC) Study
Munir, Muhammad S., Weng, Lu‐Chen , Tang, Weihong , Basu, Saonli , Pankow, James S. , Matijevic, Nena, Cushman, Mary , Boerwinkle, Eric , Folsom, Aaron R. , Munir, M Shahzeb, Pankow, James S , Tang, Weihong

Genetic Epidemiology | November 5, 2014 | Volume: 38 | Issue: 8 | Pages: 709-713

10.1002/gepi.21868 | PMID 25376901 Get It

Genitofemoral neuralgia: A review
Cesmebasi, Alper , Gielecki, Jerzy , Tubbs, R. Shane , Loukas, Marios , Yadav, Abhishek

Clinical Anatomy | November 5, 2014 | Volume: 28 | Issue: 1 | Pages: 128-135

10.1002/ca.22481 | PMID 25377757 Get It

Genitofemoral neuralgia is a cause of neuropathic pain that is often debilitating in nature. It is characterized by chronic neuropathic groin pain that is localized along the distribution of the genitofemoral nerve. The symptoms include groin pain, paresthesias, and burning sensation spreading from the lower abdomen to the medial aspect of the thigh. It may present with scrotal pain in male, while females experience symptoms radiating to the labia majora and mons pubis. Genitofemoral neuropathy has been attributed to iatrogenic nerve injury occurring during inguinal and femoral herniorrhaphy, with cases developing after both open and laparoscopic techniques. Diagnosis of genitofemoral neuralgia can be challenging, due to the overlap in sensory distribution the nerve shares with the ilioinguinal and iliohypogastric nerve. Differential nerve blocks are recommended in effort to differentiate the nerves when patients present with lower abdominal and groin pain. Once a diagnosis has been made, there exist several treatment options for genitofemoral neuralgia ranging from medical management, non‐invasive injections, and surgery. Literature has also brought light to radiofrequency ablation and cryoablation performed under ultrasound guidance as emerging treatments. The aim of the current article is to review the anatomy, diagnostic techniques, and treatment options for patients with genitofemoral neuralgia. Clin. Anat. 28:128–135, 2015. © 2014 Wiley Periodicals, Inc.